This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Includes the Inaugural North American Viral Hepatitis Elimination Summit

2018 Program Iformation 

Thank you for participating in the 2018 Canadian Liver Meeting which offered a forum for presentation and discussion of basic science, translational and clinical aspects of liver disease. This was a unique opportunity to exchange ideas, promote collaboration and foster knowledge translation among Canadian researchers, healthcare practitioners and community-based groups with interest in Hepatology.

The program featured Canadian and international speakers, the latest research presentations, state of the art symposia, and a wealth of networking opportunities with peers, trainees, allied health practitioners, and industry.

The Canadian Liver Meeting is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. Participants can claim up to a maximum of 19.5 study credits.

 

Friday - feb 9, 2018
7th Canadian Symposium on Hepatitis C

Session #1: Biomedical Research

  • DAA Induced Reversal of Immunce Senescence - Lisa Barrett, Dalhousie University
  • Increased Usage of a Public CD8 T Cell Clonotype in Spontaneously Resolved HCV Infection - Sabrina Mazouz, CRCHUM, Montréal
  • Impaired CD8+ T-cell Function is Associated with Liver Disease Severity in Chronic HCV Infection and Remains Unresolved After HCV Cure - Angela Crawley, Ottawa Hospital Research Institute

Session #2: Social, Cultural, Environmental and Population Health Research

  • Health Systems and HCV Elimination: Overcoming Challenges Through a Micro-Elimination Approach - Jeffrey Lazarus, ISGlobal, Hospital Clínic, University of Barcelona
  • Indigenous Data Sovereignty on the Path to HCV Elimination - Jennifer Walker, Laurentian University
  • HCV: Bringing Care to Patients in Rural and Remote Settings - Dustin Dapp, Simon Fraser University & Lucy Newman-Hogan, University of Guelph
  • Ontario Hepatitis C Education and Outreach Program with Immigrants and Newcomers - Fozia Tanveer, CATIE, Canad

Session #4: Health Services Research

  • Use of Data to Drive Global Policy to Eliminate HCV - Homie Razavi, Centre for Disease Analysis
  • Decreased Confirmation of Chronic Hepatitis C Infections in Correctional Institutions Compared to the Community in Ontario - Nagma Grewal, Queen's University
  • Estimation of Hepatitis C Prevalence in Canada Via a Two-Stage Back-Calculation Algorithm - Abdullah Hamadeh, University of Waterloo
  • Population-Level Cascade of Care for Hepatitis C in British Columbia: Differences over time, by gender and birth cohort - Nuria Chapinal, BC Centre for Disease Control
  • A Framework of a National Hepatitis C Elimination Strategy in Canada - Alison Marshall, University of New South Wales, Australia, CanHepC Trainee

Opening Keynote Speaker for Canadian Liver Meeting

  • HCV Policy in Action: Lessons learned from Portugal - Ricardo Baptista Leite, Member of Parliament, Lisbon, Portugal

 

Saturday - feb 10, 2018
Canadian LIver Meeting 

Breakfast Symposium

  • Tips Optimizing Outcomes - Juan Gonzalez-Abraldes, University of Alberta

Public Health and Epidemiology Program

  • Delivering HCV care to PWID: We know that DAA therapies are effective, now what? - Jason Grebely, Kirby Institute & University of New South Wales
  • Epidemiology of Liver Disease in Canada - Jennifer Flemming, Queen's University
  • What are the research gaps to monitor and evaluate the elimination of hepatitis C in Canada by 2030 - Alison Marshall, Canadian Network on Hepatitis C (CanHepC) and the Kirby Institute, UNSW Sydney

Basic Science Program

  • Mechanisms of Liver Cell Death - Gregory Gores, Mayo Clinic
  • Host-Virus Interaction in HCV Infection - Selena Sagan, McGill University

Viral Hepatitis Paper Session

  • Monocyte Exposure to HBV Antigens Leads to Activation of HBV-specific CD4 T Cells - Aman Mehrotra, University Health Network
  • Altered M1 Macrophage Phenotype May Contribute to CD8+T-cell Dysfunction in Chronic HCV Infection with Advanced Liver Fibrosis - Angela Crawley, University Health Network
  • A Retrospective Nationwide Study on Hepatitis B Epidemiology and Genotypes; The Canadian Hepatitis B Network - Carla Coffin, University of Calgary

Plenary Session: The Forgotten Hepatitides

  • Current Management of Hepatitis D and Hepatitis E - Heiner Wedemeyer, Hannover Medical School
  • Hep B and Pregnancy Update - Carla Coffin, University of Calgary

Community Liver Update #1 - Best of AASLD

  • Viral Hepatitis Debrief - Paul Kwo, Stanford University
  • NAFLD Debrief - Kymberly Watt, Mayo Clinic
  • General Hepatology Debrief - Michael Lucey, University of Wisconsin

CAHN Program

  • Sleep Wake Disturbances in Cirrhosis - Raed Hawa, University of Toronto

 

 

sunday - feb 11, 2018
canadian liver meeting

General Hepatology Paper Session

  • Occult Liver Cirrhosis Diagnosed by Transient Elastography is Frequent and Under-monitored in HIV-Infected Patients: results of a large-scale screening program - Giada Sebastiani, McGill University
  • The Impact of Obesity in Cirrhotic Patients with Septic Shock: a retrospective cohort study - Beverley Kok, University of Alberta

CASL/CLF Gold Medal Lecture

  • Hepatocellular Carcinoma: Lessons Learned - Gregory Gores, Mayo Clinic

CAHN Program

  • Case Study #1: Addition Case - Lesley Gallagher, University of Copenhagen
  • Case Study #2 - Decompensated Cirrhosis: to treat or not to treat - Liza Abraham, St. Michael's Hospital
  • Case Study #3: Mission Impossible: The challenges faced while waiting for double transplant and a HCV Treatment - Maria Stavrakis, Montreal Jewish General Hospital

Liver Transplant Symposium

  • Transplant for Metabolic Liver disease (peds) - Steve Martin, University of Calgary
  • Transplantation for Alcoholic Hepatitis - Michael Lucey, University of Wisconsin

Autoimmune Liver Disease Symposium

  • IgG4-Related Disease - Bertus Eksteen, University of Calgary

Keeping Up With The Literature

  • Top 3 Papers of 2017 (Liver) - Samuel Lee, University of Calgary
  • Top 3 Papers of 2017 (GI) - Robert Bailey, University of Alberta